154 related articles for article (PubMed ID: 17885671)
21. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.
Tedoldi S; Paterson JC; Cordell J; Tan SY; Jones M; Manek S; Dei Tos AP; Roberton H; Masir N; Natkunam Y; Pileri SA; Facchetti F; Hansmann ML; Mason DY; Marafioti T
J Pathol; 2006 Aug; 209(4):454-63. PubMed ID: 16739114
[TBL] [Abstract][Full Text] [Related]
22. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
[TBL] [Abstract][Full Text] [Related]
23. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
Ree HJ; Khan AA; Qureshi MN; Teplitz C
Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
Nicholas DS; Harris S; Wright DH
Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
[TBL] [Abstract][Full Text] [Related]
26. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
27. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
[TBL] [Abstract][Full Text] [Related]
28. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
[TBL] [Abstract][Full Text] [Related]
29. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
30. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
31. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas.
Drakos E; Leventaki V; Atsaves V; Schlette EJ; Lin P; Vega F; Miranda RN; Claret FX; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2011 Aug; 42(8):1117-24. PubMed ID: 21315423
[TBL] [Abstract][Full Text] [Related]
32. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.
Montes-Moreno S; Roncador G; Maestre L; MartÃnez N; Sanchez-Verde L; Camacho FI; Cannata J; Martinez-Torrecuadrada JL; Shen Y; Chan WC; Piris MA
Blood; 2008 Jan; 111(1):351-8. PubMed ID: 17898315
[TBL] [Abstract][Full Text] [Related]
33. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
[TBL] [Abstract][Full Text] [Related]
34. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
35. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
36. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
39. Tenascin in reactive lymph nodes and in malignant lymphomas.
Soini Y; Alavaikko M; Lehto VP; Virtanen I
Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
[TBL] [Abstract][Full Text] [Related]
40. MCL-1 expression in B-cell non-Hodgkin's lymphomas.
Cho-Vega JH; Rassidakis GZ; Admirand JH; Oyarzo M; Ramalingam P; Paraguya A; McDonnell TJ; Amin HM; Medeiros LJ
Hum Pathol; 2004 Sep; 35(9):1095-100. PubMed ID: 15343511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
